Written by The global vascular grafts market was valued at approximately US$ 2.0 Bn in 2021 and is projected to expand at a CAGR of 5.6% from 2022 to 2031, reaching more than US$ 3.7 Bn by the end of 2031. Vascular grafts are increasingly important in procedures designed to restore blood flow around blocked or narrowed arteries. They may be derived from biological tissue or manufactured using synthetic or biosynthetic materials and are used across coronary, peripheral, renal, cerebral, and other vascular procedures. Analysts attribute market growth to the rising incidence of cardiovascular and chronic kidney diseases, expansion of the geriatric population, increasing healthcare expenditure, and improvements in healthcare infrastructure. Growing awareness of vascular disorders and continued advances in minimally invasive treatment techniques are also supporting adoption.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11096
Market Size and Growth
The increasing global burden of lifestyle-related disorders is a major growth driver. Diabetes, hypertension, obesity, and physical inactivity are contributing to a growing population at risk of vascular complications. According to the International Diabetes Federation, around 527 million adults worldwide were living with diabetes in 2021, with this number projected to rise substantially in the coming decades. Cardiovascular diseases remain another significant concern, with the WHO estimating approximately 17.9 million CVD-related deaths globally in 2019. The growing patient population is expected to increase demand for bypass procedures, endovascular interventions, dialysis access, and other vascular applications. At the same time, healthcare providers are increasingly emphasizing cost-effective treatments and improved clinical outcomes as healthcare systems transition from volume-based toward value-based care.
Market Segmentation
By product, the market is segmented into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, bypass grafts, and others. Endovascular stent grafts accounted for a leading share in 2021, supported by their use in treating conditions such as abdominal aortic aneurysms through less invasive procedures. Based on source, the market comprises biological, synthetic, and biosynthetic grafts, with synthetic grafts holding a dominant position due to their mechanical properties, durability, and adaptability. By size, large-size vascular grafts represented a major segment, benefiting from availability and favorable patency rates. Application segments include coronary artery bypass, aneurysm, vascular occlusion, renal failure, critical limb ischemia, and others, while hospitals remain the leading end-user segment because of their extensive vascular and cardiovascular procedural capabilities.
Regional Analysis
North America held a leading share of the global market in 2021, with the U.S. serving as the primary contributor due to its large patient population, high prevalence of cardiovascular disease, advanced healthcare infrastructure, and strong research and development activity. Meanwhile, Asia Pacific is anticipated to record the fastest growth during the forecast period. Rising cardiovascular disease incidence in countries such as China and India, increasing healthcare investments, greater awareness of vascular diseases, and expanding access to advanced surgical procedures are creating significant opportunities across the region. Awareness initiatives led by vascular associations and growing demand for customized graft solutions are expected to further support market development.
Competitive Landscape
The global vascular grafts industry is relatively consolidated, with several established companies competing through product innovation, portfolio expansion, strategic partnerships, and mergers and acquisitions. Major participants include B. Braun SE, Becton, Dickinson and Company, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc. Companies are investing in research and development to improve graft performance, durability, biocompatibility, and procedural outcomes.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453